Immunosuppressive and antiinfectious regimens in vascular composite allograft recipients—a systematic review
Current immunosuppressive strategies in VCA lack standardization, leading to variability in outcomes and increased risks. Infection prophylaxis remains underutilized despite recipient vulnerability. There is a critical need for standardized and tailored guidelines to optimize immunosuppressive therapy and infection control, ensuring graft survival and improved patient outcomes.
Authors
- Jasper Iske (ORCID: https://orcid.org/0000-0001-8647-3092)
- Maxime Jeljeli
- Martin Kauke‐Navarro (ORCID: https://orcid.org/0000-0001-5399-4166)
- Samuel A. Knoedler (ORCID: https://orcid.org/0000-0001-5798-8003)
- Alexandre G. Lellouch (ORCID: https://orcid.org/0000-0001-8191-8662)
- Elena Hofmann (ORCID: https://orcid.org/0000-0003-4458-9278)
- Gabriel Hundeshagen (ORCID: https://orcid.org/0000-0002-6173-8602)
- Curtis L. Cetrulo (ORCID: https://orcid.org/0000-0001-7080-3894)
- Steffen Koerdt (ORCID: https://orcid.org/0000-0002-8679-8775)
- Max Heiland (ORCID: https://orcid.org/0000-0002-4987-2913)
- Leonard Knoedler (ORCID: https://orcid.org/0009-0009-4279-5669)
- Javier González
- Tobias Niederegger (ORCID: https://orcid.org/0009-0004-3065-4352)
- Thomas Schaschinger (ORCID: https://orcid.org/0009-0000-6523-1641)
Institutions
- Cedars-Sinai Medical Center (US)
- University of Arizona (US)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Yale University (US)
- Humboldt-Universität zu Berlin (DE)
- Massachusetts General Hospital (US)
- Shriners Hospitals for Children - Boston (US)
- Klinikum Ludwigshafen (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Frontiers in Transplantation
- Published
- 2025-12-18
- DOI
- https://doi.org/10.3389/frtra.2025.1714886
- Citations
- 2
- Primary Topic
- Infectious Aortic and Vascular Conditions
- Type
- article
- Field-Weighted Citation Impact
- 4.01